Evidence map›Paper›PMID 34216308›Full record

ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke.

Ji Li, Yan Ma, Xiao-Hui Miao, Ji-Dong Guo, Da-Wei Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Endothelial progenitor cell transplantation attenuates synaptic loss associated with enhancing complement receptor 3-dependent microglial/macrophage phagocytosis in ischemic mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ji LiDepartment of Neurology, Affiliated Hospital of Beihua University, 12 JieFang street, Jilin, 132011, People's Republic of China.
Yan MaDepartment of Neurology, Affiliated Hospital of Beihua University, 12 JieFang street, Jilin, 132011, People's Republic of China.
Xiao-Hui MiaoAffiliated Hospital of ChangChun University of Traditional Chinese Medicine, Changchun, 130021, People's Republic of China.
Ji-Dong GuoDepartment of Neurology, Affiliated Hospital of Beihua University, 12 JieFang street, Jilin, 132011, People's Republic of China.
Da-Wei LiDepartment of Neurology, Affiliated Hospital of Beihua University, 12 JieFang street, Jilin, 132011, People's Republic of China. lidaweiliuye@163.com.ORCID http://orcid.org/0000-0002-1204-767X
Beihua University · CNChangchun University of Chinese Medicine · CN

Funding

Education Department of Jilin Province JJkH20170063kJEducation Department of Jilin Province JJKH20190653KJ
6 · The paper itself

Abstract

Endothelial progenitor cells (EPCs) are immature endothelial cells (ECs) capable of proliferating and differentiating into mature ECs. These progenitor cells migrate from bone marrow (BM) after vascular injury to ischemic areas, where they participate in the repair of injured endothelium and new blood vessel formation. EPCs also secrete a series of protective cytokines and growth factors that support cell survival and tissue regeneration. Thus, EPCs provide novel and promising potential therapies to treat vascular disease, including ischemic stroke. However, EPCs are tightly regulated during the process of vascular repair and regeneration by numerous endogenous cytokines that are associated closely with the therapeutic efficacy of the progenitor cells. The regenerative capacity of EPCs also is affected by a range of exogenous factors and drugs as well as vascular risk factors. Understanding the functional properties of EPCs and the factors related to their regenerative capacity will facilitate better use of these progenitor cells in treating vascular disease. Here, we review the current knowledge of EPCs in cerebral neovascularization and tissue regeneration after cerebral ischemia and the factors associated with their regenerative function to better understand the underlying mechanisms and provide more effective strategies for the use of EPCs in treating ischemic stroke.

Indexed as

Brain IschemiaEndothelial Progenitor CellsIschemic StrokeStrokeHumansNeovascularization, PathologicNeovascularization, PhysiologicEndothelial progenitor cellsIschemic strokeNeovascularizationNeurogenesisStromal cell-derived factor-1

Identifiers

PMID34216308
OpenAlexW3174536928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.